Showing results (131-140 of 365) with videos related to
Sort By:
Pageof 37
The Journal of Biological Chemistry|February 14, 2006
Individual Timp deficiencies differentially impact pro-MMP-2 activationJane L English, Zamaneh Kassiri, Ilpo Koskivirta, et al.Nature Protocols|September 26, 2020
Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorVizMichael Scherer, Petr V Nazarov, Reka Toth, et al.Nature Communications|February 2, 2020
Neuronal ensemble-specific DNA methylation strengthens engram stabilityKubra Gulmez Karaca, Janina Kupke, David V C Brito, et al.Plos One|September 21, 2011
Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survivalAndreas Gast, Justo Lorenzo Bermejo, Rainer Claus, et al.International Journal of Cancer|June 12, 2012
Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer riskOdilia Popanda, Petra Seibold, Ivaylo Nikolov, et al.Oncogene|September 26, 2003
Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomasTasneem Motiwala, Kalpana Ghoshal, Anindita Das, et al.Human Pathology|May 7, 2013
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrenceMaria Christina Tsourlakis, Michael Schoop, Christoph Plass, et al.International Journal of Cancer|February 24, 2026
ID3 deficiency alters chromatin accessibility at DSB sites and enhances vulnerability to HDAC inhibitionGiuditta Della Corte, Hossam Eldesouky, Julia Puchan, et al.Cancer Research|May 19, 2007
Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinomaKristi L Bennett, Björn Hackanson, Laura T Smith, et al.Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.Pageof 37